SAN JOSE, California, April 15 /PRNewswire/ --

- AT91CAP7X-DK Includes ARM7-based Microcontroller with 80K LC FPGA

Atmel(R) Corporation (Nasdaq: ATML) today announced its AT91CAP7X-DK development kit for designers to develop, emulate, and ultimately migrate ARM7(TM)-plus-FPGA designs to Atmel's CAP7 customizable microcontrollers.

AMSTERDAM, April 15 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announced today that the U.S. Food and Drug Administration (FDA) has granted its product Rhitol(TM) Orphan Drug Designation for the treatment of chronic Graft versus Host Disease (GvHD). This complication of allogeneic bone marrow transplantation is highly disabilitating and can become life threatening when the patient is unresponsive to steroid treatment. Rhitol(TM) has completed a multicenter phase I/II study for patients with severe steroid resistant chronic GvHD. A phase III study is anticipated to start in 2008.

VALLETTA, Malta, April 15 /PRNewswire/ --

- Award Recognizes the 100 "Most Promising" Companies Driving the Future of Technology

Red Herring today announced that Mobiletech AS is a recipient of the Red Herring 100 Europe, an award given to the top 100 private technology companies based in the EMEA (Europe, Middle East and Africa) region each year.

http://prn.newscom.com/cgi-bin/pub/s?f=PRN/prnpub&p1=20080211/292641-a&v...

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

BATH, England, April 15 /PRNewswire/ --

- Vision of Grammy Award-Winning Artist & Digital Media Pioneer Peter Gabriel, Technology Available as Personal Discovery Website and White Label Solution for Content Partners

REDWOOD CITY, California, April 15 /PRNewswire/ --

- Ingenuity Pathways Analysis to be deployed broadly to researchers at Pfizer, integrated with internal solutions

Ingenuity Systems, the leading provider of information solutions for life science researchers, and Pfizer Pharmaceuticals, Inc. (NYSE: PFE), the world's largest research-based biomedical and pharmaceutical company, announced a strategic partnership today. This new multi-year partnership promotes enterprise-wide deployment of IPA, enabling more researchers to use IPA for the exploration, interpretation, and analysis of life science information. In addition, Pfizer will integrate IPA and content from the Ingenuity knowledge base with other informatics solutions used throughout the Pfizer organization.

Matter and anti-matter are believed to have been created in equal amounts when the universe came in to existence during the Big Bang, yet in the universe today there is only matter.

The quest to understand more about the mysterious neutrino particle which is thought to be responsible for this phenomenon has taken a major step forward. The Muon Ionisation Cooling Experiment (MICE) project, an accelerator research experiment for a major component of a future Neutrino Factory, has achieved an important milestone with the successful transport of a beam of muon particles along the MICE muon beam.

Observations of atmospheric and solar neutrinos have shown that they change state (oscillate), between three forms - electron, tau and muon - during their journey across the Earth or from the Sun to the Earth. This discovery is extremely significant since oscillations can only occur if neutrinos have mass and yet the Standard Model of particle physics, on which our current understanding of how our universe was created and is held together rests, assumes that neutrinos have no mass.

ATLANTA and LONDON, April 15 /PRNewswire/ --

Infosecurity Conference 2008 -- Lancope(R), Inc., the provider of the StealthWatch(TM) System, the most widely used network behaviour analysis (NBA) and response solution, today announced a panel discussion at Infosecurity Europe 2008, in which several leading universities will discuss how StealthWatch leverages NetFlow and sFlow in its delivery of NBA to secure and continuously monitor high-speed networks.

HELSINGBORG, Sweden, April 15 /PRNewswire/ -- NOLabs AB, the Swedish medtech company focusing on developing innovative Nitric Oxide-containing medical devices, today reported that it has achieved another important milestone in the development of a new preventive therapy against urinary tract infection, UTI.

PARIS, April 15 /PRNewswire/ --

- The International Transport Forum, 28-30 May 2008 in Leipzig "Transport and Energy: The Challenge of Climate Change"

NEW YORK, April 15 /PRNewswire/ --

Mark Nejmeh, President, MagKinetics Inc. will travel to Dubai to seek an Angel for his development stage renewable energy company with their patent pending technology for "A system and method for creating electricity from moving vehicular traffic." MagKinetics has been patiently and thoroughly seeking a financially qualified and socially responsible investor or group and is now reaching out to the world community to bring this opportunity directly to such investors. The company is now arranging meetings in Dubai for their executive visit on April 21 - 23, 2008.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080303/NEM113 )